Small  Growth

Mizuho Maintains Buy Rating on Arcutis Biotherapeutics

Jacob Stephan Reiterates Buy Rating on Dave (DAVE) Stock

Ondas Director Randy Seidl Sells Shares

APLD's Active Options Trading and Market Reaction to Financing

Laser Photonics released FY2025 9 Months Earnings on December 23 (EST), with actual revenue of USD 5.809 M and EPS of USD -1.3381

Roma Green Finance released FY2026 Semi-Annual Earnings on December 23, 2025 (EST), with actual revenue of USD 477.07K and EPS of USD -0.0512

Roma Green Finance released FY2026 Q1 earnings on December 23 (EST), actual revenue USD 237.51 K, actual EPS USD -0.0254

Roma Green Finance released FY2026 Q2 earnings on December 23 (EST), actual revenue USD 239.56 K, actual EPS USD -0.0257

Laser Photonics released FY2025 Q3 earnings on December 23, 2025 (EST) with actual revenue of USD 919.28 K and EPS of USD -1.0939

Ondas Holdings Executives Neil J Laird and Richard M Cohen Reduce Their Stock Holdings

Cipher Mining Director Reports Sale of Common Stock

Mirum Pharmaceuticals Director Disposes of Common Stock

D-Wave Quantum Enthusiasts Mark January 7th

Vicor CFO Reports Sale of Common Stock

Cantor Fitzgerald reiterates 'Outperform' rating on TeraWulf stock

Critical Metals Corp Shares Gap Higher

Praxis Precision Medicines Obtains FDA Approval to Redesign elsunersen's EMBRAVE3 Trial

Diginex Limited Shares Its Strategic Update on Acquisition Roadmap

Cipher Mining Inc. Acquires High-Performance Computing Site in Ohio

Diginex Limited Negotiating Terms of Acquisition of Resulticks Global Companies Pte Limited

ECD Automotive Design

A SPAC III Acquisition

Davis Commodities

CID Holdco

Can-Fite BioPharma

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

PicoCELA

Paranovus ENT Tech

Northann

DingDong

LFMD

LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend

businessinsider

LifeMD

LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend

SOUN

NVDA

The article compares Nvidia (NVDA) and SoundHound AI (SOUN) as potential AI stock investments before 2026, using TipRanks' Stock Comparison Tool. It analyzes different parameters to evaluate which stock might be the better investment choice. The article also promotes TipRanks' tools for smarter investment decisions.

- Nvidia (NVDA) and SoundHound AI (SOUN) are highlighted as notable AI stocks for 2025, each presenting unique investment opportunities.  
- A comparison of NVDA and SOUN is conducted using TipRanks' Stock Comparison Tool, evaluating various investment parameters.  
- This analysis aims to guide potential investors as they consider their options heading into 2026.

Tip Ranks

SoundHound AI

NVIDIA

NVDA vs. SOUN: Which Is the Best AI Stock to Buy Before 2026?

CDZI

Cadiz Inc. has announced a quarterly cash dividend for Q4 2025 on its 8.875% Series A Cumulative Perpetual Preferred Stock. Holders of the stock will receive $550 per whole share, while holders of depositary shares will receive $0.55 per share. The dividend is payable on January 15, 2026, to shareholders of record as of January 5, 2026.

StockTitan

Cadiz

Cadiz Inc. Declares Quarterly Dividend for Q4 2025 on Series A Cumulative Perpetual Preferred Stock | CDZI Stock News

Today, in Los Angeles, Cadiz, Inc. (NASDAQ: CDZI) (NASDAQ: CDZIP), a California-based water solutions company, revealed that its Board of Directors has approved a cash dividend for its 8.875% Series A Cumulative Perpetual. The dividend amount was not disclosed in the news article.

Unusual Whales

Cadiz Inc. declares quarterly dividend for Q4 2025 on Series A preferred stock; 8.875% rate announced.

APLD

Applied Digital's stock has more than tripled in 2025.

Applied Digital

Can Applied Digital stock double again in 2026?

Lake Street's Ryan Meyers maintains a Buy rating on LifeMD with a price target of $8.00. The analyst, covering the Consumer Cyclical sector, has an average return of -7.0% and a 34.20% success rate. The general analyst consensus for LifeMD is a Strong Buy with a $9.67 average price target.

Lake Street Keeps Their Buy Rating on LifeMD (LFMD)

ARQT

Mizuho Securities analyst Uy Ear maintains a Buy rating on Arcutis Biotherapeutics (ARQT) with a $37 target, citing strong Zoryve prescription momentum and a broad dermatology portfolio. The analyst notes sustained growth in prescriptions, aligning with optimistic sales projections and 2026 revenue guidance. This supports confidence in Arcutis's market performance and competitive edge. Guggenheim also maintains a Buy rating with a $34 target.

Arcutis Biotherapeutics

Sustained Zoryve Prescription Momentum and Broad Dermatology Portfolio Underpin Buy Rating and $37 Target on Arcutis Biotherapeutics

LifeMD, Inc. announced a quarterly cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on January 15, 2026, to shareholders of record as of January 5, 2026.

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock | LFMD Stock News

BTQ Tech (BTQ.US) has seen its stock price continue to decline as the technology sector adjusts overall. Although there have been signs of stabilization with reduced trading volume in the past two days, the market's willingness to buy remains weak. Community sentiment is divided; some bearish funds have begun to take profits, while some aggressive traders are focusing on the possibility of a rebound from oversold conditions. Recently, there have been occasional low-level accumulations by major players, indicating some forward-looking funds are taking action. If the overall market's risk appetite improves, BTQ Tech may become a spring for capital speculation— the longer it is compressed, the greater the rebound potential. It is recommended to closely monitor major player movements and replenishment actions; if short-term trading volume breaks out, combined with positive catalysts, the rebound could easily evolve into a "limit-up board" group effect. Conversely, if it continues to decline without volume, caution is still needed for repeated bottom fluctuations. In summary, whether funds are willing to ignite together after the oversold condition will be a key focus this week

Technical Forecast

BTQ Tech

Morning Trend | BTQ Tech Weakly Seeks Bottom, Is the Oversold Rebound Window About to Open?

BTQ Tech (BTQ.US) suddenly surged during yesterday's trading session, with noticeable volume in intraday transactions. Many day traders expressed that "it seems like the main force is testing the waters." The market is divided on whether it can break through the $5.5 level, with some worried about a pump and dump, while others remain bullish on the continued rotation in the tech sector. After hours, the community is hotly debating: is it a real breakthrough or a trap to lure in buyers? Recently, the enthusiasm for related sectors has risen again, with AI-related themes frequently stimulating sentiment. As a low-priced sci-tech stock, BTQ Tech quickly retraced after following the market rebound in the past few days, indicating that short-term capital operations are highly flexible. Although the technical pattern shows that the platform box has been oscillating for a week, each dip has found support around $5.1-$5.2. The key will be the sustainability after the breakout; if it can stabilize in the $5.5-$5.7 range and achieve a simultaneous increase in volume and price, the main upward opportunity is likely to be realized soon. On the other hand, if it quickly retraces with reduced volume, the speculative short positions should not be underestimated. Currently, the intraday fluctuations, market conditions, and community discussion intensity are all rising, signaling that the short-term direction may form soon. The operational suggestion is to follow the trend primarily, while being cautious about chasing after rapid surges; both volume and intraday news need to be closely monitored. BTQ Tech is currently at a "true or false breakout" judgment moment, with opportunities and risks coexisting, and trading choices must not be taken lightly

Morning Trend | BTQ Tech raises prices for testing, is it a real breakthrough or a trap for the bulls?

Telix Pharmaceuticals Ltd. faces a class action lawsuit filed by investors for alleged securities fraud, claiming false statements about prostate cancer therapeutic progress and supply chain quality. The lawsuit covers losses between February 21, 2025, and August 28, 2025, and is managed by Levi & Korsinsky, LLP. The news was generated by Public Technologies using AI and is based on Telix's original content published via ACCESS Newswire.

Reuters

Telix Pharmaceuticals

Telix Pharmaceuticals Faces Investor Class Action Over Alleged Securities Fraud

IMTE

DAIC

SELX

ALMU

SOBR

12 Information Technology stocks showed significant movement in Friday's pre-market session. Gainers included PicoCELA (+36.4%), X3 Holdings (+17.5%), CID Holdco (+9.52%), Nvni Group (+7.26%), Aeluma (+7.14%), and Schmid Group (+6.57%). Losers included Sobr Safe (-15.6%), 3 E Network (-6.46%), Integrated Media Tech (-5.87%), Semilux International (-5.0%), Global Engine Group (-4.65%), and ParaZero Technologies (-3.87%).

benzinga_article

Integrated Media

Semilux

Aeluma

Sobr Safe

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Deep Research

Entering 2025, three years into the OpenAI-led AI cycle, the industry remains in a full-on AI investment phase. Based on our recent work, Dolphin Research sees 2026 hinging on compute cost-down and on AI capex translating into deployments across software and hardware.The rollout of new hardware is the true incremental driver. Meanwhile, mass production of Tesla's Optimus is drawing closer, and humanoid robots could become the primary AI form factor, reshaping human interaction and productivity.On this premise, Dolphin Research is launching coverage on the robotics supply chain. This is Part 1.

ROBOSENSE

Fulai New Material

Orbbec

Honeywell

W-Ibeda

SANHUA

Sanhua

Hesai

HESAI-W

Keli

Lingyun Ind

BOSCH

Hanwei Electronics

XDLK

Tesla

XPeng

XPENG-W

Humanoid Robots: AI's Best Hope?

$NuScale Power(SMR.US) still sitting at bottom of the base. Had some price action early today and now sitting. A move over 17.50 and then maybe this trade works/gets going. Stops setSource: Sunrise Trader

NuScale Power

A good bull knows where the bears live. My thoughts on the bull case for 2026 along with the bear arguments that could warrant a correction next year. Substack below, as always it is free &amp; no paywalls, curious to here other people's thoughts for next year as well!Source: amit

WisdomTree Gold

Webull

WEBULL CORPORATION C/WTS 10/04/2030(TO PUR COM)

$Innodata(INOD.US) this one caught my eye on homework list.Source: Sunrise Trader

Innodata

$Walmart(WMT.US) weekly we are early in the week but note the red stick indicating a temp top on the weekly at elevated RSI. Note that since my buy in Dec 2023 price has ridden the 50ma and the 21ma. Since the pullback in April all pullbacks/basing price has held at the 21ma weekly. So this gives us another level to watch for basing. Also note the strong volume the last 4 weeks have had so this again gives us an idea that a pullback might be shallow and the 21 might hold on the weekly as this gives the daily plenty of room to unwind. I also put a stochastic on this chart to show that it is turning south and has yet to put in a bear cross. Prior times when it gave a bear cross with temp top sticks it pulled in to help unwind. All the while the 21ma held price with the exception of April and that is where you can see price caught on the 50ma and stochs put in a bull cross buy signal. Price is what pays and indicators are secondary but can help confirm what price is/isn't doin. Only use them if they help you. Many get paralyzed by them and if you are one, then take them off your chart and follow PRICE and candle action.Source: Sunrise Trader

Walmart

Rush Street Interactive

$Oklo(OKLO.US)OKLO is now at 87. If it can adjust to around 80 next week, I think it's a good opportunity for long-term investment. Don't exit too soon because the chance of doubling next year is very high. Also, SMR is nearing its end, and it's about time. I entered a bit early, but I'm still holding because I considered buying in batches. Now, anything above $17.50 is worth considering, so $18.30 is already very close to the bottom. If it could go even lower, that would be ideal. But buying now wouldn't be too bad. This is the nuclear energy sector, and I believe there will definitely be a rally next year. As everyone has said before, the endgame of AI is energy. Another thing is the space concept. News came out that Musk's Space X will IPO tomorrow, and the valuation has gone from 800 billion to 1.5 trillion. This IPO is one of the largest in history, so there will be a good wave of speculation when it happens. But don't rush to chase it now because it's still early.

Oklo

GraniteShares 2x Short TSLA Daily ETF

Direxion Daily TSLA Bull 2X Shares

AXS TSLA Bear Daily ETF

XI2CSOPTSLA-U

XL2CSOPTSLA

XI2CSOPTSLA

GraniteShares 2x Long TSLA Daily ETF

$Applied Digital(APLD.US) all out of the name no shares left made good profit on the rest of the holding. The name goes back on go-to listSource: Sunrise Trader

$CleanSpark(CLSK.US) and $Applied Digital(APLD.US) each a rung of the ladder sold for excellent $. Still own both just less shares.Source: Sunrise Trader

CleanSpark

CLEANSPARK INC C/WTS 29/12/2028 (TO PUR COM)